News
04-17-2010, 05:15 AM
Merrimack Pharmaceuticals, Inc. announced today that it will present pre-clinical data on MM-121 and MM-111, the two lead candidates in the company's pipeline of five novel cancer antibodies, at the 101st Annual Meeting of the American Association for Cancer Research (AACR) being held April 17 – 21, 2010, in Washington, D.C.
More... (http://www.news-medical.net/news/20100417/Pre-clinical-data-on-MM-121-and-MM-111-to-be-presented-at-AACR-2010.aspx)
More... (http://www.news-medical.net/news/20100417/Pre-clinical-data-on-MM-121-and-MM-111-to-be-presented-at-AACR-2010.aspx)